<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00904813</url>
  </required_header>
  <id_info>
    <org_study_id>98/240</org_study_id>
    <nct_id>NCT00904813</nct_id>
  </id_info>
  <brief_title>The Stockholm III Trial on Different Preoperative Radiotherapy Regimens in Rectal Cancer</brief_title>
  <acronym>Stockholm III</acronym>
  <official_title>A Prospective Randomized Trial on Different Preoperative Radiotherapy Regimens in Rectal Cancer, Stockholm III.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Swedish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are theoretical reasons to believe that radiotherapy (RT) given in larger fractions
      during a shorter period of time might result in more late side effects than giving a
      conventional, more protracted RT in patients with rectal cancer. In addition, the optimum
      timing of surgery after RT, with respect to postoperative morbidity, mortality and potential
      downsizing of the tumour is not known.

      To address these questions, a prospective randomized multicentre trial was initiated, the
      Stockholm III trial, in which patients with primarily resectable rectal cancer were
      randomized to short-course preoperative RT (5x5 Gy) followed by surgery within one week or
      after 4-8 weeks or long-course preoperative RT(25x2 Gy) followed by surgery after 4-8 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preoperative radiotherapy (RT) is recommended to many patients with localised rectal cancer,
      not previously treated with pelvic RT. However, the optimum fractionation, the timing of
      surgery and the best use of concomitant chemotherapy remains controversial. Short-course,
      preoperative RT may induce both acute and late morbidity and has been claimed to cause more
      morbidity than long-course preoperative RT. There are theoretical reasons to believe that RT
      given in larger fractions during a shorter period of time might result in more late side
      effects than giving a conventional, more protracted RT. In addition, the optimum timing of
      surgery after RT, with respect to postoperative morbidity, mortality and potential downsizing
      of the tumour is not known.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 1998</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to recurrence</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>acute and late toxicity</measure>
    <time_frame>30 days and 5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">840</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>1. RT 5x5 Gy + surgery within 1 week</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RT=Preoperative radiotherapy Gy=Gray</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2.RT 5x5 Gy + surgery after 4-8 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RT=radiotherapy Gy= Gray</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3.RT 25x2 Gy + surgery after 4-8 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RT= radiotherapy Gy= Gray</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Preoperative radiotherapy</intervention_name>
    <description>5 times 5 Gray during five consecutive days, preferably Monday - Friday, with a four-field box technique, including the primary tumour and the primary and secondary lymph nodes in the pelvis.</description>
    <arm_group_label>1. RT 5x5 Gy + surgery within 1 week</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Preoperative radiotherapy</intervention_name>
    <description>5 times 5 Gray during five consecutive days, preferably Monday - Friday, with a four-field box technique, including the primary tumour and the primary and secondary lymph nodes in the pelvis.</description>
    <arm_group_label>2.RT 5x5 Gy + surgery after 4-8 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Preoperative radiotherapy</intervention_name>
    <description>2 Gy in 25 fractions during 5 weeks, total dose 50 Gy with a four-field box technique, including the primary tumour and the primary and secondary lymph nodes in the pelvis.</description>
    <arm_group_label>3.RT 25x2 Gy + surgery after 4-8 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy confirmed clinically resectable rectal adenocarcinoma within 15 cm from the
             anal verge

          -  Planned for bowel resection with an abdominal procedure.

        Exclusion Criteria:

          -  Distant metastases

          -  Locally advanced unresectable tumors

          -  Planned for local excision

          -  Previous radiotherapy to the abdominal or pelvic region

          -  Severe ischemic heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Martling, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mora and Falun Hospital</name>
      <address>
        <city>Mora, Falun</city>
        <state>Dalarna</state>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danderyds Hospital</name>
      <address>
        <city>Danderyd</city>
        <state>Stockholm</state>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norrtälje Hospital</name>
      <address>
        <city>Norrtälje</city>
        <state>Stockholm</state>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Södertälje Hospital</name>
      <address>
        <city>Södertälje</city>
        <state>Stockholm</state>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eskilstuna Hospital</name>
      <address>
        <city>Eskilstuna</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsingborg Hospital</name>
      <address>
        <city>Helsingborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MAS University Hospital</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vrinnevi Hospital</name>
      <address>
        <city>Norrköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastrocentrum Kirurgi, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ersta Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Görans Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Visby Hospital</name>
      <address>
        <city>Visby</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2009</study_first_submitted>
  <study_first_submitted_qc>May 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2009</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Anna Martling</investigator_full_name>
    <investigator_title>Associate Professor, Senior Consultant Surgeon</investigator_title>
  </responsible_party>
  <keyword>Rectal cancer</keyword>
  <keyword>Preoperative radiotherapy</keyword>
  <keyword>Timing of Surgery</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

